Awarded NIH Grant to Develop Therapies for Alzheimer’s Disease

In Apr 2021, AivoCode was awarded SBIR Phase I grant from National Institute of Aging at NIH for developing therapies for treating Alzheimer’s disease. These therapies are directed to a novel target to reverse vascular deficit as a therapeutic intervention in Alzheimer’s disease.

See NIH award details

Kristin English

I help people build and grow successful, sustainable businesses they’re passionate about.

I do this by building websites and setting up ways for them to automatically collect email addresses, send emails, schedule appointments and process payments. 

In essence, I help people with online businesses turn prospective customers into clients. I enable their vision through technology. 

Learn More: www.kristinenglish.com

https://www.kristinenglish.com
Previous
Previous

AivoCode presents at RESI March 2022

Next
Next

AivoCode Awarded NIH Grant to Develop a Novel Therapeutic for Traumatic Brain Injury